Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer
Mariana Chávez‐MacGregor, Xiudong Lei, Hui Zhao, et al.
JAMA Oncology (2021) Vol. 8, Iss. 1, pp. 69-69
Open Access | Times Cited: 193

Showing 1-25 of 193 citing articles:

Vaccines and therapeutics for immunocompromised patients with COVID-19
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 84
Obesity as an independent risk factor for COVID-19 severity and mortality
Borna Tadayon Najafabadi, Daniel Rayner, Kamyar Shokraee, et al.
Cochrane library (2023) Vol. 2023, Iss. 6
Open Access | Times Cited: 40
Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
Meredith Leston, Willam Elson, José M. Ordóñez‐Mena, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106110-106110
Open Access | Times Cited: 15
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations
Christian Caglevic, Christian Rolfo, Ignacio Gil‐Bazo, et al.
JCO Global Oncology (2022), Iss. 8
Open Access | Times Cited: 37
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 29
Mortality risk in patients with obesity and COVID-19 infection: a systematic review and meta-analysis
Rachelle Haber, Malak Ghezzawi, Houry Puzantian, et al.
Metabolism (2024) Vol. 155, pp. 155812-155812
Closed Access | Times Cited: 8
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
Firas El Chaer, Jeffery J. Auletta, Roy F. Chemaly
Blood (2022) Vol. 140, Iss. 7, pp. 673-684
Open Access | Times Cited: 28
COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Juan Ignacio Ruiz, María A. López-Olivo, Yimin Geng, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006246-e006246
Open Access | Times Cited: 18
Novel pneumonia score based on a machine learning model for predicting mortality in pneumonia patients on admission to the intensive care unit
Bin Wang, Yuanxiao Li, Ying Tian, et al.
Respiratory Medicine (2023) Vol. 217, pp. 107363-107363
Closed Access | Times Cited: 16
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
Issam Raad, Ray Hachem, Masayuki Nigo, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 15
Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity
Simeng Bu, Léna Royston, Tsoarello Mabanga, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Methodological challenges using routine clinical care data for real-world evidence: a rapid review utilizing a systematic literature search and focus group discussion
Michelle Pfaffenlehner, Max Behrens, Daniela Zöller, et al.
BMC Medical Research Methodology (2025) Vol. 25, Iss. 1
Open Access
Urban and Rural Differences in Cancer Treatment Disruption Among Patients With COVID‐19: An Analysis of the US ASCO COVID‐19 in Oncology Registry
Yu Chen Lin, Kea Turner, Oliver T. Nguyen, et al.
Cancer Medicine (2025) Vol. 14, Iss. 2
Open Access
A Comprehensive Pan‐Cancer Analysis of COVID‐19 Booster Vaccination Efficacy and Safety
Yinghui Peng, Yan Zhang, Shan Zeng, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
Impact of the COVID-19 Pandemic on the Treatment of Head and Neck Cancers
Max Lee, Andrey Finegersh, Michelle Chen
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1424-1424
Open Access
Higher-Order Biomarkers Through Network Motif Mining: A COVID-19 Case Study
Nicholas Chahley, Armstrong Murira, Natalie Nakhla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Efficacy of Ayurvedic treatment given to cancer patients in the prevention of COVID-19 – A Retrospective Cohort Study at Integrated Cancer Treatment and Research Centre, Wagholi
Sadanand Sardeshmukh, Vineeta Deshmukh, Vidya S. Gupta, et al.
Journal of Ayurveda and Integrative Medicine (2025) Vol. 16, Iss. 2, pp. 101045-101045
Open Access
Clinical Outcomes of Hospitalized Immunocompromised Patients With COVID-19 and the Impact of Hyperinflammation: A Retrospective Cohort Study
Xinxin Zhang, Han Xiao-bo, Chenglong Li, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3385-3397
Open Access
Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)
Mathias Brügel, Léa Letrillart, Camille Evrard, et al.
European Journal of Cancer (2022) Vol. 166, pp. 8-20
Open Access | Times Cited: 22
Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury
Si‐Chi Xu, Wei Wu, Shuyang Zhang
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2703-2713
Open Access | Times Cited: 20
Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020
Xuesong Han, Xin Hu, Jingxuan Zhao, et al.
JAMA Oncology (2022) Vol. 8, Iss. 11, pp. 1696-1696
Open Access | Times Cited: 19
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients
Fabio Fiorino, Annalisa Ciabattini, Anna Sicuranza, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
Joaquín Martínez‐López, Javier de la Cruz, Rodrigo Gil-Manso, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1497-1497
Open Access | Times Cited: 11
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer
Marco Tagliamento, Alessandra Gennari, Matteo Lambertini, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 15, pp. 2800-2814
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top